Item 16. Form 10-K Summary

24K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

None.

Index

Ameriprise Financial, Inc.

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

AMERIPRISE FINANCIAL, INC.

Registrant

Date:February 22, 2024By/s/ Walter S. Berman
Walter S. Berman Executive Vice President and Chief Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacity and on the dates indicated.

Date:February 22, 2024By/s/ James M. Cracchiolo
James M. Cracchiolo Chairman and Chief Executive Officer (Principal Executive Officer and Director)
Date:February 22, 2024By/s/ Walter S. Berman
Walter S. Berman Executive Vice President and Chief Financial Officer (Principal Financial Officer)
Date:February 22, 2024By/s/ Dawn M. Brockman
Dawn M. Brockman Senior Vice President and Controller (Principal Accounting Officer)
Date:February 22, 2024By/s/ Dianne Neal Blixt*
Dianne Neal Blixt Director
Date:February 22, 2024By/s/ Amy DiGeso*
Amy DiGeso Director
Date:February 22, 2024By/s/ Armando Pimentel, Jr.*
Armando Pimentel, Jr. Director
Date:February 22, 2024By/s/ Robert F. Sharpe, Jr.*
Robert F. Sharpe, Jr. Director
Date:February 22, 2024By/s/ Brian T. Shea*
Brian T. Shea Director
Date:February 22, 2024By/s/ W. Edward Walter III*
W. Edward Walter III Director

Index

Ameriprise Financial, Inc.

Date:February 22, 2024By/s/ Christopher J. Williams*
Christopher J. Williams Director
*By/s/ Walter S. Berman
Walter S. Berman Executive Vice President and Chief Financial Officer

*Walter S. Berman, by signing his name hereto on the 22nd day of February, 2024 does hereby sign this document pursuant to powers of attorney duly executed by the Directors named, filed with the Securities and Exchange Commission on behalf of such Directors as Exhibit 24 to this Form 10-K, all in the capacities and on the date stated, such persons being the majority of the Directors of the Registrant.

Index

Ameriprise Financial, Inc.

Schedule I - Condensed Financial Information of Registrant

(Parent Company Only)

Condensed Statements of Operations - Years ended December 31, 2023, 2022 and 2021180
Condensed Balance Sheets - December 31, 2023 and 2022181
Condensed Statements of Cash Flows - Years ended December 31, 2023, 2022 and 2021182
Notes to Condensed Financial Information of Registrant183

Index

Ameriprise Financial, Inc.

Schedule I — Condensed Financial Information of Registrant Condensed Statements of Operations (Parent Company Only)
Years Ended December 31,
20232022**(1)**2021**(1)**
(in millions)
Revenues
Net investment income$77$16$27
Other revenues569
Total revenues822236
Banking and deposit interest expense3582
Total net revenues471434
Expenses
Distribution expenses4647
Interest and debt expense138104102
General and administrative expense306265258
Total expenses490373367
Pretax loss before equity in earnings of subsidiaries(443)(359)(333)
Income tax provision142139157
Loss before equity in earnings of subsidiaries(585)(498)(490)
Equity in earnings of subsidiaries, net of tax3,1413,6473,907
Net income2,5563,1493,417
Other comprehensive income (loss), net of tax780(1,904)(498)
Total comprehensive income (loss)$3,336$1,245$2,919

(1) Certain prior period amounts have been restated. See Note 1 for more information.

See Notes to Condensed Financial Information of Registrant.

Index

Ameriprise Financial, Inc.

Schedule I — Condensed Financial Information of Registrant Condensed Balance Sheets (Parent Company Only)
December 31,
20232022**(1)**
(in millions, except share amounts)
Assets
Cash and cash equivalents$519$361
Investments841831
Loans to subsidiaries489249
Due from subsidiaries246338
Receivables4926
Land, buildings, equipment, and software, net of accumulated depreciation of $791 and $874, respectively265216
Investments in subsidiaries6,9745,843
Other assets1,5801,262
Total assets$10,963$9,126
Liabilities and Equity
Liabilities:
Accounts payable and accrued expenses$1,229$999
Due to subsidiaries347107
Borrowings from subsidiaries580602
Long-term debt3,3982,819
Other liabilities680796
Total liabilities6,2345,323
Equity:
Common shares ($0.01 par value; shares authorized, 1,250,000,000; shares issued, 336,780,893 and 335,864,062, respectively)33
Additional paid-in capital9,8249,517
Retained earnings21,90519,918
Treasury shares, at cost (236,607,681 and 230,585,072 shares, respectively)(25,237)(23,089)
Accumulated other comprehensive income (loss), net of tax, including amounts applicable to equity investments in subsidiaries(1,766)(2,546)
Total equity4,7293,803
Total liabilities and equity$10,963$9,126

(1) Certain prior period amounts have been restated. See Note 1 for more information.

See Notes to Condensed Financial Information of Registrant.

Index

Ameriprise Financial, Inc.

Schedule I — Condensed Financial Information of Registrant Condensed Statements of Cash Flows (Parent Company Only)
Years Ended December 31,
20232022**(1)**2021**(1)**
(in millions)
Cash Flows from Operating Activities
Net income$2,556$3,149$3,417
Equity in earnings of subsidiaries(3,141)(3,647)(3,907)
Dividends received from subsidiaries3,0252,5124,027
Other operating activities, primarily with subsidiaries453226343
Net cash provided by (used in) operating activities2,8932,2403,880
Cash Flows from Investing Activities
Available-for-Sale securities:
Proceeds from sales4——
Maturities, sinking fund payments and calls4315393
Purchases(38)(124)(82)
Proceeds from sales of other investments—71
Purchase of other investments(10)(1)(16)
Proceeds from sales of land, buildings, equipment and software——1
Purchase of land, buildings, equipment and software(87)(70)(28)
Contributions to subsidiaries(324)(743)(1,291)
Return of capital from subsidiaries—20739
Repayment of loans to subsidiaries1,9921,9602,701
Issuance of loans to subsidiaries(2,232)(1,726)(2,937)
Other, net2——
Net cash provided by (used in) investing activities(650)(337)(1,519)
Cash Flows from Financing Activities
Dividends paid to shareholders(550)(534)(511)
Repurchase of common shares(2,127)(1,978)(2,030)
Issuance of long-term debt, net of issuance costs1,3354954
Repayments of long-term debt(760)(510)(9)
Borrowings from subsidiaries1,0031,210244
Repayments of borrowings from subsidiaries(951)(1,034)(403)
Exercise of stock options——1
Other, net(35)(18)99
Net cash provided by (used in) financing activities(2,085)(2,369)(2,605)
Net increase (decrease) in cash and cash equivalents158(466)(244)
Cash and cash equivalents at beginning of period3618271,071
Cash and cash equivalents at end of period$519$361$827
Supplemental Disclosures:
Interest paid on debt$129$98$95
Income taxes paid, net23391173
Non-cash dividends from subsidiaries77——
Non-cash contributions to subsidiaries——52

(1) Certain prior period amounts have been restated. See Note 1 for more information.

See Notes to Condensed Financial Information of Registrant.

Index

Ameriprise Financial, Inc.

Schedule I — Condensed Financial Information of Registrant

Notes to Condensed Financial Information of Registrant

(Parent Company Only)

1. Basis of Presentation

The accompanying Condensed Financial Statements include the accounts of Ameriprise Financial, Inc. (the “Parent Company”) and, on an equity basis, its subsidiaries and affiliates. The Condensed Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles. The financial information of the Parent Company should be read in conjunction with the Consolidated Financial Statements and Notes of Ameriprise Financial, Inc. and its subsidiaries (“Ameriprise Financial”). Parent Company revenues and expenses, other than interest and debt expense, are primarily related to intercompany transactions with subsidiaries and affiliates.

In August 2018, the Financial Accounting Standards Board (“FASB”) issued an Accounting Standards Update (“ASU”) related to long-duration insurance contracts (ASU 2018-12). When our insurance subsidiaries adopted the standard effective January 1, 2023 with a transition date of January 1, 2021 (the “transition date”), opening equity was adjusted for the adoption impacts to retained earnings and accumulated other comprehensive income (loss) (“AOCI”) and prior periods were restated. The adoption impact as of January 1, 2021 was a reduction in total equity of $1.9 billion, of which $0.9 billion and $1.0 billion were reflected in retained earnings and AOCI, respectively.

2. Investments

On December 23, 2020, RiverSource Life Insurance Company (“RiverSource Life”) issued a $500 million unsecured 3.5% surplus note due December 31, 2050 to the Parent Company. The surplus note is subordinate in right of payment to the prior payment in full of RiverSource Life’s obligations to policyholders, claimants and beneficiaries and all other creditors. No payment of principal or interest shall be made without the prior approval of the Minnesota Department of Commerce and such payments shall be made only from RiverSource Life’s statutory surplus. Interest payments, which commenced on June 30, 2021, are due semi-annually in arrears on June 30 and December 31. Subject to the preceding conditions, RiverSource Life may prepay all or a portion of the principal at any time. The held-to-maturity investment was $500 million as of both December 31, 2023 and 2022 and is recorded in Investments on the Parent Company’s Condensed Balance Sheets. For the years ended December 31, 2023, 2022 and 2021, interest income was $18 million, $18 million and $17 million, respectively, and is reported in Net investment income on the Parent Company’s Condensed Statements of Operations.

The Parent Company invested in the residual tranche of an asset backed security structure issued by Ameriprise Advisor Financing, LLC (“AAF”) and in the residual tranche of an asset backed security structure issued by Ameriprise Advisor Financing 2, LLC (“AAF 2”), both subsidiaries of the Parent Company. The asset backed securities are collateralized by a portfolio of loans issued to advisors affiliated with Ameriprise Financial Services, LLC (“AFS”), a subsidiary of the Parent Company. During the third quarter of 2022, the Parent Company redeemed the outstanding residual tranche issued by AAF, realizing a $23 million loss, and invested $30 million in a new residual tranche issued by AAF 2. As of December 31, 2023 and 2022, the fair value of the residual tranche issued by AAF 2 was $30 million and $27 million, respectively. The fair value of the residual tranche is reported in Investments on the Parent Company’s Condensed Balance Sheets. For each of the years ended December 31, 2023, 2022 and 2021, interest income was $7 million and is reported in Net investment income on the Parent Company’s Condensed Statements of Operations.

3. Debt

All of the debt of Ameriprise Financial is borrowings of the Parent Company, except as indicated below.

  • As of both December 31, 2023 and 2022, Ameriprise Financial had $201 million of borrowings from the Federal Home Loan Bank of Des Moines, which is collateralized with commercial mortgage backed securities.

  • As of December 31, 2023 and 2022, Ameriprise Financial debt included $1 million and $2 million, respectively, of other subsidiary lease obligations.

4. Borrowings from Subsidiaries

The Parent Company has intercompany lending arrangements with its subsidiaries. At the end of each business day, taking into consideration all legal and regulatory requirements associated with its subsidiaries, the Parent Company is entitled to draw on all funds in specified bank accounts. Repayment of all or a portion of the funds is due on demand. As of December 31, 2023 and 2022, the Company had $375 million and $411 million, respectively, available for repayment due on demand. The Parent Company also has revolving credit agreements with its subsidiaries as the borrower aggregating $1.3 billion and $1.1 billion as of December 31, 2023 and 2022, respectively, of which $205 million and $191 million was outstanding as of December 31, 2023 and 2022, respectively.

5. Guarantees, Commitments and Contingencies

The Parent Company is the guarantor for operating leases of certain subsidiaries. All consolidated legal, regulatory and arbitration proceedings, including class actions of Ameriprise Financial are potential or current obligations of the Parent Company. The Parent Company has committed revolving credit agreements with its subsidiaries as the lender aggregating $363 million and $361 million as of December 31, 2023 and 2022, respectively, of which $246 million and nil was outstanding as of December 31, 2023 and 2022, respectively.

The Parent Company and Ameriprise Certificate Company (“ACC”) entered into a Capital Support Agreement on March 2, 2009, pursuant to which the Parent Company agrees to commit such capital to ACC as is necessary to satisfy applicable minimum capital requirements. Effective April 30, 2014, this agreement was amended to revise the maximum commitment to $50 million. For the years ended December 31, 2023, 2022 and 2021, ACC did not draw upon the Capital Support Agreement and had met all applicable capital requirements.

Index

Ameriprise Financial, Inc.

AFS entered into a Financial Industry Regulatory Authority (“FINRA”) approved subordinated loan agreement with the Parent Company on December 15, 2014 for regulatory net capital purposes. The agreement consists of a $200 million secured demand note. The note is secured by cash and securities equal to the principal value of the note pledged by the Parent Company. As of both December 31, 2023 and 2022, AFS had not made a demand of the principal amount.

Ameriprise Enterprise Investment Services, Inc. (“AEIS”) entered into a FINRA approved subordinated loan agreement with the Parent Company on January 25, 2017 for regulatory net capital purposes. Under this agreement, AEIS borrowed $60 million from the Parent Company with an initial term of five years to be repaid no later than January 25, 2022. Both companies have the option to renew the agreement in one year-increments in perpetuity. The agreement was renewed in January 2022 and each year thereafter, extending the current maturity date to January 25, 2025.

6. Subsequent Events

On January 30, 2024, the Parent Company contributed cash of $15 million to Ameriprise Advisor Capital, LLC. On February 14, 2024, the Parent Company received a cash dividend of $60 million from AMPF Holding, LLC. These actions were declared subsequent to the balance sheet date.

Previous: Item 15. Exhibits and Financial Statement Schedules